Amplia Therapeutics Ltd.ASX: ATX

FDA Clearance - MIS416 Investigational New Drug Application

Jun 21, 2017 at 2:56 AM UTC · Issued by Amplia Therapeutics Ltd.

Amplia Therapeutics Ltd has released a press release.

View Attachment